hydroquinone has been researched along with Diabetes Mellitus, Type 2 in 3 studies
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Excerpt | Relevance | Reference |
---|---|---|
"daily for 7 days) provokes the onset of type II diabetes mellitus in a model of insulin resistance, the obese Zucker rat." | 1.31 | Endothelial dysfunction accompanies a pro-oxidant, pro-diabetic challenge in the insulin resistant, obese Zucker rat in vivo. ( Anggård, EE; Carrier, MJ; Desai, KM; Laight, DW, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Fuentes, E | 1 |
Arauna, D | 1 |
Araya-Maturana, R | 1 |
Laight, DW | 2 |
Desai, KM | 2 |
Gopaul, NK | 1 |
Anggård, EE | 2 |
Carrier, MJ | 2 |
1 review available for hydroquinone and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Regulation of mitochondrial function by hydroquinone derivatives as prevention of platelet activation.
Topics: Blood Platelets; COVID-19; Diabetes Mellitus, Type 2; Humans; Hydroquinones; Mitochondria; Platelet | 2023 |
2 other studies available for hydroquinone and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Pro-oxidant challenge in vivo provokes the onset of NIDDM in the insulin resistant obese Zucker rat.
Topics: Animals; Antimetabolites; Antioxidants; Blood Glucose; Body Weight; Buthionine Sulfoximine; Diabetes | 1999 |
Endothelial dysfunction accompanies a pro-oxidant, pro-diabetic challenge in the insulin resistant, obese Zucker rat in vivo.
Topics: Acetylcholine; Animals; Antioxidants; Area Under Curve; Body Weight; Buthionine Sulfoximine; Cyclic | 2000 |